Moderna, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Moderna, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 92% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 90% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $11 tied up three years earlier. Less money tied up than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-4.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 57% of Healthcare companies in United States.
Cash Locked Ratio
$6For every $100 of sales, $6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $11 tied up three years earlier.
Less money tied up than 85% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 90%
Sales fell 90% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-90% / -52%In 3 years sales changed by -90% while total assets changed by -52%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-44.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 71% of Healthcare companies in United States.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Lower than 56% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 90% of Healthcare companies in United States.
Tangible Net Worth Ratio
99%Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 92% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Moderna, Inc. made a loss over the last year. Moderna, Inc. owes $0.38 for every $1 it owns. Moderna, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossModerna, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
11.97The share price is 11.97 times Moderna, Inc.'s book value per share, higher than 88% of Healthcare companies in United States.
Market cap
$80.9 BThe total market value of all of Moderna, Inc.'s shares at today's price (share price × number of shares), larger than 97% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$6.8 BWhat Moderna, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$16.93Net worth divided by the number of shares. The share price of $202.63 is 12.0 times this, which is the P/B above.
Return on equity (ROE)
-39.0%Moderna, Inc. lost 39.0% of its shareholders' money over the last year, higher than 55% of Healthcare companies in United States.
Owes vs Owns
0.38×Moderna, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Dividend yield
NoneModerna, Inc. does not currently pay a dividend.
Revenue growth
-40%Revenue fell 40% in the year to Dec 2025, and shrank 53% a year on average over 3 years.
Profit growth
LossModerna, Inc. made a loss in each of the last two years.
Profit margin
-146.8%Moderna, Inc. lost $147 for every $100 of revenue.
Interest cover
Not coveredModerna, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashModerna, Inc. held $4.5 B more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Moderna, Inc.: $80.9 B ÷ $6.8 B (30 Jun 2026) = 12.0.
What is Moderna, Inc.'s return on equity?
Moderna, Inc. lost 39.0% of its shareholders' money over the last year, higher than 55% of Healthcare companies in United States.
How much does Moderna, Inc. owe compared with what it owns?
Moderna, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Does Moderna, Inc. pay a dividend?
No. Moderna, Inc. does not currently pay a dividend.
Is Moderna, Inc.'s revenue growing?
Revenue fell 40% in the year to Dec 2025, and shrank 53% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.